These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37045707)

  • 41. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma.
    Merhe A; Labban M; Hout M; Bustros G; Abou Heidar N; El-Asmar JM; Bulbul M; El Hajj A
    Urol Oncol; 2020 Dec; 38(12):930.e1-930.e6. PubMed ID: 32736935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
    Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
    BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pelvic lymph-node staging with
    Jansen BHE; Bodar YJL; Zwezerijnen GJC; Meijer D; van der Voorn JP; Nieuwenhuijzen JA; Wondergem M; Roeleveld TA; Boellaard R; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):509-520. PubMed ID: 32789599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study.
    Karpinski MJ; Hüsing J; Claassen K; Möller L; Kajüter H; Oesterling F; Grünwald V; Umutlu L; Kleesiek J; Telli T; Merkel-Jens A; Hüsing A; Kesch C; Herrmann K; Eiber M; Hoberück S; Meyer PT; Kind F; Rahbar K; Schäfers M; Stang A; Hadaschik BA; Fendler WP
    Lancet Oncol; 2024 Sep; 25(9):1188-1201. PubMed ID: 39089299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold.
    Venclovas Z; Muilwijk T; Matjosaitis AJ; Jievaltas M; Joniau S; Milonas D
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801231
    [No Abstract]   [Full Text] [Related]  

  • 48. The diagnostic accuracy of
    Rajwa P; Heidenreich J; Drzezga A; Schmidt M; Shariat SF; Heidenreich A
    Prostate; 2024 Jan; 84(1):74-78. PubMed ID: 37750292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additional Parameters to the Briganti Nomogram for Predicting Pelvic Lymph Node Metastasis in Prostate Cancer.
    Gul A; Ekici O
    Arch Esp Urol; 2024 Jul; 77(6):614-621. PubMed ID: 39104228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b.
    Porcaro AB; Panunzio A; Orlando R; Montanaro F; Baielli A; Artoni F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Patuzzo GM; Veccia A; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Tafuri A; Cerruto MA; Antonelli A
    Int Braz J Urol; 2024; 50(4):450-458. PubMed ID: 38743063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients.
    Peilleron N; Seigneurin A; Herault C; Verry C; Bolla M; Rambeaud JJ; Descotes JL; Long JA; Fiard G
    World J Urol; 2021 May; 39(5):1489-1497. PubMed ID: 32583038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
    Draulans C; Everaerts W; Isebaert S; Van Bruwaene S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Laenen A; Weynand B; Defraene G; Vanhoutte E; De Meerleer G; Haustermans K
    J Urol; 2020 Apr; 203(4):713-718. PubMed ID: 31718396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A machine learning-assisted decision-support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection.
    Hou Y; Bao ML; Wu CJ; Zhang J; Zhang YD; Shi HB
    BJU Int; 2019 Dec; 124(6):972-983. PubMed ID: 31392808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.
    Ma TM; Gafita A; Shabsovich D; Juarez J; Grogan TR; Thin P; Armstrong W; Sonni I; Nguyen K; Lok V; Reiter RE; Rettig MB; Steinberg ML; Kupelian PA; Yang DD; Muralidhar V; Chu C; Feng F; Savjani R; Deng J; Parikh NR; Nickols NG; Elashoff D; Czernin J; Calais J; Kishan AU
    Eur Urol Oncol; 2022 Feb; 5(1):100-103. PubMed ID: 33602654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy.
    Huang C; Song G; Wang H; Lin Z; Wang H; Ji G; Zhang S; Guo Y; Li J; Bao Z; Hong P; Du Y; Li P; He Q; He S; Gong Y; Wang X; Zhou L
    Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):116-126. PubMed ID: 31383954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer.
    Meijer D; de Barros HA; van Leeuwen PJ; Bodar YJL; van der Poel HG; Donswijk ML; Hendrikse NH; van Moorselaar RJA; Nieuwenhuijzen JA; Oprea-Lager DE; Vis AN
    J Urol; 2021 Jun; 205(6):1655-1662. PubMed ID: 33530746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.
    Goto Y; Utsumi T; Maruo M; Kurozumi A; Noro T; Tanaka S; Sugawara S; Chiba K; Miyazaki K; Inoue A; Komaru A; Fukasawa S; Imamura Y; Sakamoto S; Nakatsu H; Suzuki H; Ichikawa T; Nagata M
    Int J Urol; 2023 Aug; 30(8):659-665. PubMed ID: 37130793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
    Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H
    BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.